These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 19785782

  • 1. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM, Voskuyl AE, Serné EH, Smulders YM.
    Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
    [Abstract] [Full Text] [Related]

  • 2. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E, Devulder B.
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [Abstract] [Full Text] [Related]

  • 3. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M, Pizzorni C, Sulli A.
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract] [Full Text] [Related]

  • 4. [Raynauds phenomenon. Diagnosis and treatment].
    Hofstee HM, Voskuyl AE, Serné EH, Smulders YM.
    Ned Tijdschr Geneeskd; 2009 May 30; 153(22):1074-81. PubMed ID: 19757751
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective nailfold capillaroscopy evaluation of Raynaud's phenomenon in children and adolescents.
    Piotto DG, Hilário MO, Carvalho NS, Len CA, Andrade LE, Terreri MT.
    Acta Reumatol Port; 2013 May 30; 38(2):114-21. PubMed ID: 24141348
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
    Schlager O, Kiener HP, Stein L, Hofkirchner J, Zehetmayer S, Ristl R, Perkmann T, Smolen JS, Koppensteiner R, Gschwandtner ME.
    Scand J Rheumatol; 2014 May 30; 43(3):226-33. PubMed ID: 24517537
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P.
    Rev Prat; 1998 Oct 01; 48(15):1659-64. PubMed ID: 9814067
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Nailfold capillaroscopy in children and adolescents with rheumatic diseases].
    Petry DG, Terreri MT, Len CA, Hilário MO.
    Acta Reumatol Port; 2008 Oct 01; 33(4):395-400. PubMed ID: 19107084
    [Abstract] [Full Text] [Related]

  • 19. Computerized nailfold video capillaroscopy--a new tool for assessment of Raynaud's phenomenon.
    Anderson ME, Allen PD, Moore T, Hillier V, Taylor CJ, Herrick AL.
    J Rheumatol; 2005 May 01; 32(5):841-8. PubMed ID: 15868619
    [Abstract] [Full Text] [Related]

  • 20. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
    Ingegnoli F, Boracchi P, Gualtierotti R, Lubatti C, Meani L, Zahalkova L, Zeni S, Fantini F.
    Arthritis Rheum; 2008 Jul 01; 58(7):2174-82. PubMed ID: 18576359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.